BioNTech SE
BNTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001776985
In the last 90 days, BioNTech SE insiders filed 0 open-market purchases and 10 sales; 283 institutions reported holding it in 13F filings for Q2 2026, worth $4.36B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q3 2022
Institutional positions in BioNTech SE as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 264
- −25 vs. Q2 2022
- Shares held
- 37.1M
- +3.67M (+11.0%) vs. Q2 2022
- Total value
- $5.01B
- +$22.4M (+0.4%) vs. Q2 2022
- New holders
- 24
- 75 more added
- Sold out
- 49
- 100 more reduced
4 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BNTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 283 | $4.36B |
| Q1 2026 | 274 | $4.22B |
| Q4 2025 | 285 | $4.56B |
| Q3 2025 | 254 | $4.97B |
| Q2 2025 | 258 | $5.72B |
| Q1 2025 | 279 | $4.71B |
| Q4 2024 | 303 | $5.79B |
| Q3 2024 | 297 | $5.24B |
| Q2 2024 | 286 | $3.30B |
| Q1 2024 | 287 | $3.78B |
| Q4 2023 | 282 | $4.28B |
| Q3 2023 | 252 | $4.01B |
| Q2 2023 | 253 | $4.05B |
| Q1 2023 | 282 | $4.88B |
| Q4 2022 | 320 | $5.97B |
| Q3 2022 | 264 | $5.01B |
| Q2 2022 | 293 | $4.99B |
| Q1 2022 | 286 | $5.90B |
| Q4 2021 | 355 | $9.08B |
| Q3 2021 | 336 | $10.0B |
| Q2 2021 | 284 | $7.84B |
| Q1 2021 | 226 | $3.25B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding BioNTech SE; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Migdal Insurance & Financial Holdings Ltd. | 0 | $0 | 0.00% | −705−100.0% | Sold out |
| CSS LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −360−100.0% | Sold out |
| Sterling Investment Advisors, Ltd. | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| International Biotechnology Trust PLC | 0 | $0 | 0.00% | −3,847−100.0% | Sold out |
| ACG Wealth | 0 | $0 | 0.00% | −101−100.0% | Sold out |
| Patriot Financial Group Insurance Agency, LLC | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −43−100.0% | Sold out |
| Venture Visionary Partners LLC | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Itau Unibanco Holding S.A. | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Heritage Wealth Advisors | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Harvest Group Wealth Management, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Steward Financial Group LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Quintet Private Bank (Europe) S.A. | – | – | – | – | Not filed |
| Exane Derivatives | – | – | – | – | Not filed |
| Fieldpoint Private Securities, LLC | – | – | – | – | Not filed |
| Private Capital Group, LLC | – | – | – | – | Not filed |